Answers are grounded in this paper and cite their sources.
Collectively, this issue presents cutting-edge research across urologic oncology, from patient-centered decisionmaking to molecular insights and advanced imaging techniques.Among these, the study by Professor Kang et al. [1] is selected as the Editors' Pick for its innovative single-cell profiling and potential to transform the management of metastatic prostate cancer through precision medicine.We invite readers to explore the full breadth of this month's contributions, reflecting the rapid evolution and multidisciplinary scope of urologic oncology. Prostate CancerThe molecular complexity of metastatic hormonesensitive cancer (mHSPC) is further explored by Professor Minyong Kang and Professor Seong Soo Jeon of Samsung Medical Center, Department of Urology [1].Through integrated single-cell RNA and whole tran scriptome sequencing, they identify a distinct, highly ag gressive cell cluster associated with poor prognosis.Their proposed 14-gene signature may offer novel avenues for patient stratification and targeted therapy.
No takes yet. Share an insight, caveat, or question.
Cheol Kwak (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: